Sublocade
Sublocade is an extended-release, once-monthly subcutaneous injection formulation of buprenorphine used to treat moderate to severe opioid use disorder (OUD). Its clinical and pharmacological effects are derived directly from the active ingredient, buprenorphine. [1] (https://pmc.ncbi.nlm.nih.gov/articles/PMC7442141/), [2] (https://pdf.hres.ca/dpd_pm/00048406.PDF), [3] (https://m.youtube.com/shorts/Tau96pD8m48) Core Pharmacological Mechanisms • Partial Mu-Opioid Receptor Agonist: Buprenorphine binds to mu-opioid receptors in the brain but exhibits lower intrinsic activity (partial activation) compared to full agonists like heroin, methadone, or oxycodone. This provides enough receptor stimulation to suppress withdrawal symptoms and cravings without producing intense euphoria. [1] (https://go.drugbank.com/drugs/DB00921), [2] (https://www.medicalnewstoday.com/articles/drugs-sublocade-how-it-works), [3] (https://www.youtube.com/shorts/kdhmEsAW_z4) • High Receptor Affinity: Buprenorp...